INVESTOR RELATIONS

PRESS RELEASES

9-Nov-2006 AMARIN REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS
3-Nov-2006 AMARIN ANNOUNCES THIRD QUARTER 2006 EARNINGS CONFERENCE CALL
2-Nov-2006 AMARIN CORPORATION TO PRESENT AT COWEN AND COMPANY 7TH GLOBAL HEALTH CARE CONFERENCE
1-Nov-2006 AMARIN CORPORATION TO PRESENT AT RODMAN & RENSHAW EIGHTH ANNUAL HEALTHCARE CONFERENCE
19-Oct-2006 AMARIN ANNOUNCES SUCCESSFUL $18.7 MILLION FUNDRAISING
11-Oct-2006 AMARIN ANNOUNCES GRANT OF PATENT IN THE UNITED STATES FOR MIRAXION IN HUNTINGTON'S DISEASE
25-Sep-2006 AMARIN TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
8-Aug-2006 AMARIN TO PRESENT AT THE BANK OF AMERICA 2006 SPECIALTY PHARMACEUTICALS CONFERENCE
3-Aug-2006 AMARIN REPORTS SECOND QUARTER 2006 RESULTS
27-Jul-2006 AMARIN COMPLETES TARGET PATIENT ENROLLMENT IN EUROPEAN PHASE III TRIAL OF MIRAXION™ IN HUNTINGTON’S DISEASE
27-Jul-2006 AMARIN CONCLUDES AGM
26-Jul-2006 AMARIN ANNOUNCES SECOND QUARTER 2006 EARNINGS CONFERENCE CALL
13-Jul-2006 AMARIN FILES REPLACEMENT UNIVERSAL SHELF REGISTRATION STATEMENT
11-Jul-2006 AMARIN LISTS ON AIM AND IEX
29-Jun-2006 AMARIN COMPLETES TARGET PATIENT ENROLLMENT IN NORTH AMERICAN PHASE III TRIAL OF MIRAXION™ IN HUNTINGTON’S DISEASE
9-Jun-2006 AMARIN ANNOUNCES INTENTION TO LIST ON AIM AND IEX MARKETS
17-May-2006 AMARIN ACQUIRES PARKINSON'S DISEASE DRUG CANDIDATE
12-May-2006 AMARIN TO PRESENT AT BANK OF AMERICA HEALTH CARE CONFERENCE
11-May-2006 AMARIN REPORTS FIRST QUARTER 2006 RESULTS
9-May-2006 AMARIN ANNOUNCES FIRST QUARTER 2006 EARNINGS CONFERENCE CALL
Page 1 of 2